Sun Pharma Stands By Share Offer For Israel’s Taro Pharma
This article was originally published in PharmAsia News
Executive Summary
India’s Sun Pharma said it plans to stick with its bid to shareholders of Israel’s Taro Pharmaceuticals to buy the rest of the firm beyond the 66% Sun already owns.